Loading cancer entity…
Loading cancer entity…
Clinical trials
26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06798363 | Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma | recruiting | Phase 2 / Phase 3 | 32 | West China HospitalOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07669545 | Risk Stratification and Treatment Decisions in Infantile Hemangioma With Minimal or Arrested Growth(IH-MAGRST) | not yet recruiting | — | 150 | West China HospitalOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT07665177 | Abrupt Discontinuation Versus Gradual Tapering of Propranolol in Infantile Hemangioma(PROIHSTOP) | not yet recruiting | Phase 4 | 110 | West China HospitalOTHER | 1 | Jun 24, 2026 | clinicaltrials |
Data updated 4 days agoSource updated Sep 21, 2026source: clinicaltrials